47 signals · alpha_vantage, bluesky, h1b_lca +2 more
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Moderate stress signals detected across available public data.
Elevated risk signals — operational or reputational pressure patterns observed.
Signal data from 2 sources places Abbott Laboratories in the Medical Devices / Diagnostics space at moderate workforce stress signals with elevated risk indicators.
Signals for Abbott Laboratories were collected from 2 sources. Aggregate signal sentiment appears broadly cautionary. The stress score stands at 58/100 with a risk score of 90/100. Signal coverage is sufficient to support a preliminary assessment.
What this means
Moderate internal stress paired with elevated risk signals — conditions bear watching.
🚨 Abbott Laboratories will pay $385 million to settle claims over powdered infant formula manufacturing issues. Three whistleblowers will receive $69 million from the settlement related to defects at the Sturgis, Michigan plant. #Abbott #InfantFormula #WhistleblowerSettlement
Three whistleblowers will receive $69 million from the settlement related to defects at the Sturgis, Michigan plant.
Abbott Laboratories will pay 385 million dollars to settle a baby formula lawsuit. Canada introduces a 36 billion dollar productivity tax incentive. Iranian spies are targeting Windows machines with Chosen Brick malware. Widow's Bay wins 14 Emmy awards.
Abbott Laboratories will pay 385 million dollars to settle a baby formula lawsuit.
Diversified health care products company.
Based on 47 signals across 5 sources · snapshot 16 Sept 2026
Strong — enough signals from diverse sources to trust this score.
Overall community sentiment for Abbott Laboratories is negative based on public signals as of 16 Sept 2026.
Based on 47 signals across 5 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
AI-generated from public signals — may be incomplete. Based on 4 recent signals.
This summary is generated from publicly available review and signal data. It is intended as an indicative overview only and should not be used as the sole basis for employment, investment, or business decisions. Signal volume and source diversity may limit representativeness.
AI summaries are generated from public signals and may not reflect the full picture.
Abbott Laboratories says that it will pay $385 million to resolve claims tied to an investigation and lawsuit brought by the Justice Department related to its manufacturing and 2022 recall of powdered infant formula at a Michigan facility.